Company intelligence / Profile preview

BioPalace

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

BioPalace is a newly launched royalty financing platform aimed at helping late-stage and commercial-stage biotech and pharma companies raise non-dilutive capital by monetizing future royalty or milestone revenues; no drug candidates or clinical results, as this is a financial platform, not a therapeutic developer.

Industry: Investors

Partnerships

Early biotech/pharma partners (names not disclosed; onboarding first cohort)

Beyond the preview

Go deeper on BioPalace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPalace.

Explore the full profile